{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:51:51Z","timestamp":1778903511907,"version":"3.51.4"},"reference-count":75,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T00:00:00Z","timestamp":1609200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Russian Scientific Foundation","award":["18-15-00372"],"award-info":[{"award-number":["18-15-00372"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>One of the target drugs for plaque psoriasis treatment is apremilast, which is a selective phosphodiesterase 4 (PDE4) inhibitor. In this study, 34 moderate-to-severe and severe plaque psoriasis patients from Russia were treated with apremilast for 26 weeks. This allowed us to observe the effectiveness of splitting patient cohorts based on clinical outcomes, which were assessed using the Psoriasis Area Severity Index (PASI). In total, 14 patients (41%) indicated having an advanced outcome with delta PASI 75 after treatment; 20 patients indicated having moderate or no effects. Genome variability was investigated using the Illumina Infinium Global Screening Array. Genome-wide analysis revealed apremilast therapy clinical outcome associations at three compact genome regions with undefined functions situated on chromosomes 2, 4, and 5, as well as on a single single-nucleotide polymorphism (SNP) on chromosome 23. Pre-selected SNP sets were associated with psoriasis vulgaris analysis, which was used to identify four SNP-associated targeted therapy efficiencies: IL1\u03b2 (rs1143633), IL4 (IL13) (rs20541), IL23R (rs2201841), and TNF\u03b1 (rs1800629) genes. Moreover, we showed that the use of the global polygenic risk score allowed for the prediction of onset psoriasis in Russians. Therefore, these results can serve as a starting point for creating a predictive model of apremilast therapy response in the targeted therapy of patients with psoriasis vulgaris.<\/jats:p>","DOI":"10.3390\/jpm11010020","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T10:04:46Z","timestamp":1609236286000},"page":"20","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1104-7694","authenticated-orcid":false,"given":"Dmitry A.","family":"Verbenko","sequence":"first","affiliation":[{"name":"State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, bldg 6, 107076 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arfenya E.","family":"Karamova","sequence":"additional","affiliation":[{"name":"State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, bldg 6, 107076 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-4745","authenticated-orcid":false,"given":"Olga G.","family":"Artamonova","sequence":"additional","affiliation":[{"name":"State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, bldg 6, 107076 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry G.","family":"Deryabin","sequence":"additional","affiliation":[{"name":"State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, bldg 6, 107076 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0567-7734","authenticated-orcid":false,"given":"Alexander","family":"Rakitko","sequence":"additional","affiliation":[{"name":"Genotek Ltd., Nastavnicheskiipereulok 17\/1, 105120 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandr","family":"Chernitsov","sequence":"additional","affiliation":[{"name":"Genotek Ltd., Nastavnicheskiipereulok 17\/1, 105120 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Krasnenko","sequence":"additional","affiliation":[{"name":"Genotek Ltd., Nastavnicheskiipereulok 17\/1, 105120 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artem","family":"Elmuratov","sequence":"additional","affiliation":[{"name":"Genotek Ltd., Nastavnicheskiipereulok 17\/1, 105120 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria S.","family":"Solomka","sequence":"additional","affiliation":[{"name":"State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, bldg 6, 107076 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey A.","family":"Kubanov","sequence":"additional","affiliation":[{"name":"State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, bldg 6, 107076 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation and Treatment of Psoriasis. A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.05.008","article-title":"The current landscape of psoriasis genetics in 2020","volume":"99","author":"Ogawa","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"ref_3","first-page":"500","article-title":"Skin Lesions Cytokines in Moderate and Severe Psoriasis as Predictors for the Type 4 Phosphodiesterase inhibitor (Apremilast) Therapy Effectiveness","volume":"75","author":"Kubanov","year":"2020","journal-title":"Ann. Russ. Acad. Med. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture","volume":"97","author":"Stuart","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jmg.22.6.492","article-title":"HLA antigens in psoriasis and psoriatic arthritis","volume":"22","author":"Woodrow","year":"1985","journal-title":"J. Med. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/archderm.1994.01690020082014","article-title":"The Genetics of Psoriasis","volume":"130","author":"Elder","year":"1994","journal-title":"Arch. Derm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.137.11.1447","article-title":"The Genetics of Psoriasis 2001: The Odyssey Continues","volume":"137","author":"Elder","year":"2001","journal-title":"Arch. Derm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-\u03baB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/sj.jid.5701255","article-title":"Polymorphisms of the IL12B and IL23R genes are associated with psoriasis","volume":"128","author":"Nair","year":"2008","journal-title":"J. Invest. Derm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1093\/hmg\/dds295","article-title":"Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes","volume":"21","author":"Julia","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"15382","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"24","author":"Tsoi","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chen, H., Poon, A., Yeung, C., Helms, C., Pons, J., Bowcock, A.M., Kwok, P.Y., and Liao, W. (2011). A genetic risk score combining ten psoriasis risk loci improves disease prediction. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019454"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Yin, X., Cheng, H., Lin, Y., Wineinger, N.E., Zhou, F., Sheng, Y., Yang, C., Li, P., Li, F., and Shen, C. (2015). A Weighted Polygenic Risk Score Using 14 Known Susceptibility Variants to Estimate Risk and Age Onset of Psoriasis in Han Chinese. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125369"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Stawczyk-Macieja, M., R\u0119ba\u0142a, K., Szczerkowska-Dobosz, A., Wysocka, J., Cybulska, L., Kapi\u0144ska, E., Hara\u015b, A., Miniszewska, P., and Nowicki, R. (2016). Evaluation of psoriasis genetic risk based on five susceptibility markers in a population from northern Poland. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163185"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kisiel, B., Kisiel, K., Szyma\u0144ski, K., Mackiewicz, W., Bia\u0142o-W\u00f3jcicka, E., Uczniak, S., Fogtman, A., Iwanicka-Nowicka, R., Koblowska, M., and Kossowska, H. (2017). The association between 38 previously reported polymorphisms and psoriasis in a Polish population: High predicative accuracy of a genetic risk score combining 16 loci. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179348"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14740338.2020.1744562","article-title":"An update on the safety of apremilast for the treatment of plaque psoriasis","volume":"19","author":"Shavit","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.14412\/1995-4484-2018-722-726","article-title":"New opportunities in the treatment of psoriasis and psoriatic arthritis","volume":"56","author":"Kubanov","year":"2018","journal-title":"Rheumatol. Sci. Pract."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1759720X10381432","article-title":"Apremilast: A novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases","volume":"2","author":"Schett","year":"2010","journal-title":"Adv. Musculoskelet Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Simard, M., Morin, S., Rioux, G., S\u00e9guin, R., Loing, E., and Pouliot, R.A. (2020). Tissue-Engineered Human Psoriatic Skin Model to Investigate the Implication of cAMP in Psoriasis: Differential Impacts of Cholera Toxin and Isoproterenol on cAMP Levels of the Epidermis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155215"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.15275\/rusomj.2020.0310","article-title":"The effect of apremilast therapy on skin cytokine levels in patients with psoriasis","volume":"9","author":"Kubanov","year":"2020","journal-title":"Russ. Open Med. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrd.2016.234","article-title":"Genome-wide association studies of drug response and toxicity: An opportunity for genome medicine, Nat","volume":"16","author":"Giacomini","year":"2017","journal-title":"Rev. Drug Discov."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrg.2016.12","article-title":"The genetics of drug efficacy: Opportunities and challenges","volume":"17","author":"Nelson","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2217\/pgs-2017-0143","article-title":"Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis","volume":"19","author":"Reolid","year":"2018","journal-title":"Pharmacogenomics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e1228","DOI":"10.1002\/mgg3.1228","article-title":"Neuronal ceroid lipofuscinosis in the Russian population: Two novel mutations and the prevalence of heterozygous carriers","volume":"8","author":"Kozina","year":"2020","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","article-title":"The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019","volume":"47","author":"Buniello","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.gene.6363645","article-title":"Cytokine gene polymorphism in human disease: On-line databases","volume":"1","author":"Bidwell","year":"1999","journal-title":"Genes Immun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000455945","article-title":"Associations between STAT Gene Polymorphisms and Psoriasis in Northeastern China","volume":"233","author":"Zhou","year":"2017","journal-title":"Dermatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1744-9081-7-23","article-title":"Modulation of cortisol responses to the DEX\/CRH test by polymorphisms of the interleukin-1beta gene in healthy adults","volume":"7","author":"Sasayama","year":"2011","journal-title":"Behav. Brain Funct."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/jid.2013.485","article-title":"Polymorphisms in IL-1B distinguish between psoriasis of early and late onset","volume":"134","author":"Hebert","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_30","first-page":"613086","article-title":"Genetics of psoriasis and pharmacogenetics of biological drugs","volume":"2013","author":"Cabaleiro","year":"2013","journal-title":"Autoimmune Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7133","DOI":"10.1007\/s11033-014-3596-5","article-title":"Autoimmune diseases association study with the KIAA1109-IL2-IL21 region in a Tunisian population","volume":"41","author":"Bouzid","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/exd.12577","article-title":"IL6 -174G>C polymorphism is associated with an increased risk of psoriasis but not response to treatment","volume":"24","author":"Ostasz","year":"2015","journal-title":"Exp Derm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-2133.2001.04143.x","article-title":"Cytokine gene polymorphisms in psoriasis","volume":"144","author":"Craven","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00011-012-0458-2","article-title":"Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: A meta-analysis","volume":"61","author":"Lee","year":"2012","journal-title":"Inflamm. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/gene.2009.11","article-title":"Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis","volume":"10","author":"Elder","year":"2009","journal-title":"Genes Immun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.gene.6364451","article-title":"Variants in the 5q31 cytokine gene cluster are associated with psoriasis","volume":"9","author":"Chang","year":"2008","journal-title":"Genes Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1080\/14740338.2017.1361404","article-title":"Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis","volume":"16","author":"Murdaca","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium; A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Liu, Y., Helms, C., Liao, W., Zaba, L.C., Duan, S., Gardner, J., Wise, C., Miner, A., MJ Malloy, M.J., and Pullinger, C.R. (2008). A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet., 4.","DOI":"10.1371\/journal.pgen.1000041"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ng.693","article-title":"Genome-wide association analysis identifies three psoriasis susceptibility loci","volume":"42","author":"Stuart","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00011-012-0509-8","article-title":"Association of IL23R polymorphisms with psoriasis and psoriatic arthritis: A meta-analysis","volume":"61","author":"Zhu","year":"2012","journal-title":"Inflamm. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1007\/s11033-010-0601-5","article-title":"Meta-analysis of TYK2 gene polymorphisms association with susceptibility to autoimmune and inflammatory diseases","volume":"38","author":"Tao","year":"2011","journal-title":"Mol. Biol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2217\/pgs.14.125","article-title":"PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis","volume":"15","author":"Julia","year":"2014","journal-title":"Pharmacogenomics"},{"key":"ref_45","first-page":"331","article-title":"Genetic polymorphism in psoriasis and its meaning for the treatment efficacy in the future","volume":"35","author":"Adamski","year":"2018","journal-title":"Postepy Derm. Alergol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajhg.2009.04.001","article-title":"Multilocus Bayesian meta-analysis of gene-disease associations","volume":"84","author":"Newcombe","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"ref_47","first-page":"40","article-title":"Association between psoriasis and polymorphisms in the TNF, IL12B, and IL23R genes in Spanish patients","volume":"23","author":"Cabaleiro","year":"2013","journal-title":"Eur. J. Derm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/bjd.12142","article-title":"Investigation of 20 non-HLA (human leucocyte antigen) psoriasis susceptibility loci in Chinese patients with psoriatic arthritis and psoriasis vulgaris","volume":"168","author":"Yang","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/ard.2011.150102","article-title":"Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis","volume":"70","author":"Bowes","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/jid.2014.517","article-title":"A Single SNP Surrogate for Genotyping HLA-C*06:02 in Diverse Populations","volume":"135","author":"Stuart","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5021\/ad.2015.27.2.128","article-title":"TNF, IL12B, and IFNG Gene Polymorphisms in Serbian Patients with Psoriasis","volume":"27","author":"Popadic","year":"2015","journal-title":"Ann. Derm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/annrheumdis-2011-200802","article-title":"Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort","volume":"71","author":"Bowes","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1038\/ncomms7046","article-title":"Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis","volume":"6","author":"Bowes","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/FPC.0000000000000233","article-title":"HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients","volume":"26","author":"Caldarola","year":"2016","journal-title":"Pharm. Genom."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/jmedgenet-2013-101787","article-title":"Association analyses identifying two common susceptibility loci shared by psoriasis and systemic lupus erythematosus in the Chinese Han population","volume":"50","author":"Li","year":"2013","journal-title":"J. Med. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cei.12888","article-title":"A preliminary study of new single polymorphisms in the T helper type 17 pathway for psoriasis in the Korean population","volume":"187","author":"Kim","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40169-015-0054-5","article-title":"Psoriasis drug development and GWAS interpretation through in silico analysis of transcription factor binding sites","volume":"4","author":"Swindell","year":"2015","journal-title":"Clin. Transl. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/jid.2015.103","article-title":"Association with Genetic Variants in the IL-23 and NF-\u03baB Pathways Discriminates between Mild and Severe Psoriasis Skin Disease","volume":"135","author":"Nikamo","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mgene.2018.10.010","article-title":"Analysis of association between cytokine gene polymorphisms and psoriatic disease in Russians of East Siberia","volume":"19","author":"Smolnikova","year":"2019","journal-title":"Meta Gene"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1038\/ncomms7916","article-title":"Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility","volume":"6","author":"Yin","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2015.03.049","article-title":"Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)","volume":"73","author":"Papp","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/bjd.14164","article-title":"Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: A phase III, randomized controlled trial (ESTEEM 2)","volume":"173","author":"Paul","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jdv.14598","article-title":"Apremilast in psoriasis\u2014A prospective real-world study","volume":"32","author":"Vujic","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Augustin, M., Kleyn, C.E., Conrad, C., Sator, P.G., St\u00e5hle, M., Eyerich, K., and Cordey, M. Characteristics and Outcomes of Patients Treated With Apremilast in the Real World: Results From the APPRECIATE Study. J. Eur. Acad. Dermatol. Venereol., 2020.","DOI":"10.1111\/jdv.16431"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4103\/ijd.IJD_194_19","article-title":"Real-World Insight on Apremilast Therapy in Patients with Plaque Psoriasis: Indian Experience","volume":"65","author":"De","year":"2020","journal-title":"Indian J. Derm."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Calautti, E., Avalle, L., and Poli, V. (2018). Psoriasis: A STAT3-Centric View. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010171"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.0022-202x.2001.01642.x","article-title":"Promoter polymorphisms of the genes encoding tumor necrosis factor-\u03b1 and interleukin-1\u03b2 are associated with different subtypes of psoriasis characterized by early and late disease onset","volume":"118","author":"Reich","year":"2002","journal-title":"J. Investig. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1093\/hmg\/ddz175","article-title":"Genome-wide association analysis of 350,000 Caucasians from the UK Biobank identifies novel loci for asthma, hay fever and eczema","volume":"28","author":"Johansson","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1398-9995.2009.01988.x","article-title":"Contribution of functional variation in the IL13 gene to allergy, hay fever and asthma in the NSHD longitudinal 1946 birth cohort","volume":"64","author":"Black","year":"2009","journal-title":"Allergy"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00011-012-0566-z","article-title":"Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn\u2019s disease and psoriasis","volume":"62","author":"Safrany","year":"2013","journal-title":"Inflamm. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2018.10.002","article-title":"Identification of novel susceptibility genes associated with seven autoimmune disorders using whole genome molecular interaction networks","volume":"97","author":"Kara","year":"2019","journal-title":"J. Autoimmun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1002\/1873-3468.12744","article-title":"Krebs cycle rewired for macrophage and dendritic cell effector functions","volume":"591","author":"Ryan","year":"2017","journal-title":"FEBS Lett."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.molcel.2020.04.002","article-title":"Cytokine-like Roles for Metabolites in Immunity","volume":"78","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/mol.117.111062","article-title":"G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?","volume":"93","author":"Sriram","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cellsig.2007.10.005","article-title":"Regulating gene transcription in response to cyclic AMP elevation","volume":"20","author":"Sands","year":"2008","journal-title":"Cell Signal."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/1\/20\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:47:15Z","timestamp":1760179635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/1\/20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,29]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["jpm11010020"],"URL":"https:\/\/doi.org\/10.3390\/jpm11010020","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,29]]}}}